Cite Filings / AVTX / 0001628280-19-014944

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

Avalo Therapeutics, Inc. Filed 2019-12-11 Acc 0001628280-19-014944

Documents 1

425 Prospectus/Communication re Business Combination , a8-kaamendment1xaevimerger.htm

Around this filing

2019-12-23 425 Prospectus/Communication re Business Combination
2019-12-11 425 Prospectus/Communication re Business Combination
2019-12-11 8-K/A Material agreement · Unregistered share sale · Regulation FD disclosure
2019-12-11 4 Changes in Ownership
2019-12-11 4 Changes in Ownership
2019-12-11 4 Changes in Ownership
2019-12-05 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a8-kaamendment1xaevimerger.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…